Jennifer Fraser

Title: Jennifer Fraser: Innovator in Pharmaceutical Preparations

Introduction

Jennifer Fraser is a notable inventor based in London, Canada. She has made significant contributions to the field of pharmaceuticals, particularly in the development of methods for inhibiting tumor growth. With a total of 3 patents to her name, her work is paving the way for advancements in cancer treatment.

Latest Patents

Fraser's latest patents focus on pharmaceutical preparations and methods for inhibiting tumors. One of her inventions provides pharmaceutical compositions aimed at inhibiting the growth of various cancers, including prostatic adenocarcinoma, stomach cancer, breast cancer, endometrial, ovarian cancers, and benign prostate hyperplasia (BPH). The pharmaceutical composition includes human rHuPSP94, along with antigenic portions and functionally equivalent polypeptides. Additionally, her invention incorporates a mixture of these components with anticancer drugs, which can be administered in appropriate dosages to patients suffering from these conditions. The anticancer drugs may include mitomycin, idarubicin, cisplatin, 5-fluoro-uracil, methotrexate, adriamycin, daunomycin, taxol, and their derivatives.

Career Highlights

Throughout her career, Jennifer Fraser has worked with several companies, including Kotinos Pharmaceuticals Inc. and Aenorasis Pharmaceuticals and Medical Devices. Her experience in these organizations has contributed to her expertise in pharmaceutical innovations.

Collaborations

Some of her notable coworkers include Seema Garde and Madhulika Baijal-Gupta. Their collaboration has likely enhanced the research and development efforts in their respective fields.

Conclusion

Jennifer Fraser's contributions to pharmaceutical innovations, particularly in cancer treatment, highlight her role as a significant inventor in the industry. Her work continues to inspire advancements in medical science and improve patient outcomes.